US7047231052 - PEAR (XNAS)
Pear Therapeutics, Inc. Aktie
Kein Kurs
Rendimiento
Día | Semana | Mes | 3 meses | 6 meses | 1 año | 5 años |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | -99,95 % |
Perfil de la empresa para Pear Therapeutics, Inc. Acción
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.
Datos de la empresa para Pear Therapeutics, Inc. Acción
Nombre Pear Therapeutics, Inc.
Empresa Pear Therapeutics, Inc.
Símbolo PEAR
Sitio web https://peartherapeutics.com
Mercado principal
NASDAQ
ISIN US7047231052
Tipo de valor Acción
Sector Healthcare
Industria Medical - Healthcare Information Services
CEO Mr. Christopher D. T. Guiffre J.D., M.B.A., MBA
País Estados Unidos de América
Moneda USD
Empleados 0,2 T
Dirección 200 State Street, 02109 Boston
Fecha de OPV 2021-03-31
ID Changes
Date | From | To |
---|---|---|
06.12.2021 | THMA | PEAR |
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | PEAR |
More Shares
Investors who Pear Therapeutics, Inc. hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.